DSG2

We have over 20,000 different genes in the body. These genes are like instruction manuals for how to build a protein, and each protein has an important function that helps to keep our body working how it should. The DSG2 gene makes a protein called desmoglein 2. Our body is made up of billions of cells. Desmoglein 2 helps to make structures called desmosomes, which work to hold cells together. By doing this, they stabilize and strengthen the various different tissues that make up our bodies. Desmosomes can also help with communication within the cell. This communication helps to tell the cell when it’s time to divide to make more new cells, or when it’s time for that cell to die, which are both very important.

If someone has a harmful change (called a pathogenic variant) in one of their DSG2 genes, then their body does not make as much desmoglein 2 protein as it should. If there is not enough desmoglein 2 protein, then cells do not have as strong of a bond. This leads to a higher rate of cell death and damage because the connections between cells are not as durable. Because desmosomes help with cell communication, not having enough of them can also mean that these messages do not get delivered, which can further contribute to cell death.

This progressive cell death is what can lead to the damage in the heart muscles, which can lead to health issues such as arrhythmogenic right ventricular cardiomyopathy and familial dilated cardiomyopathy.

Pathogenic variants in the DSG2 gene are passed through the family in an autosomal dominant pattern, meaning that anyone who carries the variant has a 50% chance to pass it down to any children they have. Women and men both have the DSG2 gene and have the same chances to inherit and pass down pathogenic variants.

Genetic Testing for DSG2

Genetic testing for mutations in DSG2 is currently available, but there are a few different ways to approach testing:

  • Single site analysis: Testing specific to a known pathogenic variant in the family
  • Full gene sequencing and rearrangement analysis: Comprehensive testing to search for all currently detectable pathogenic variants in the gene
  • Gene panels: Newer, more broadly based gene tests that would include not only the DSG2 gene, but other genes known or suspected to be associated with hereditary cardiovascular disease.

Last updated on Feb 21st, 2019